Iradimed Corp
IRMDNasdaqCIK 1325618HealthcareFiscal year ends Dec 31
Reports and events: 191 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:16 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-068576 |
| 2026-10-3008:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-068454 |
| 2026-08-1814:03 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-057617 |
| 2026-07-3116:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051402 |
| 2026-07-3108:15 ET | 8-K | 8.01 Other events | 0001628280-26-051240 |
| 2026-06-2410:22 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-045059 |
| 2026-05-0116:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-029325 |
| 2026-05-0108:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029125 |
| 2026-04-3016:14 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001628280-26-028903 |
| 2026-03-0616:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-024691 |
| 2026-02-1008:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-012356 |
| 2025-12-0808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119090 |
| 2025-11-0316:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-105538 |
| 2025-11-0308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105298 |
| 2025-09-0316:30 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001558370-25-011853 |
| 2025-09-0208:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011834 |
| 2025-08-0116:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-009987 |
| 2025-08-0108:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-009933 |
| 2025-06-2309:49 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008791 |
| 2025-05-2916:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008245 |
| 2025-05-0516:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006308 |
| 2025-05-0507:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006220 |
| 2025-04-3008:30 ET | DEF 14A | Proxy statementPeriod 2025-06-19 | 0001558370-25-005933 |
| 2025-03-0616:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002389 |
| 2025-02-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-000907 |
| 2025-01-1012:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-000117 |
| 2024-10-3116:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014056 |
| 2024-10-3108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014005 |
| 2024-08-0116:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-010609 |
| 2024-08-0108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-010533 |
| 2024-06-2016:05 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-009354 |
| 2024-06-0708:30 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008988 |
| 2024-06-0308:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-008847 |
| 2024-05-0216:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-006537 |
| 2024-05-0208:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-006460 |
| 2024-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001558370-24-006105 |
| 2024-03-0108:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002235 |
| 2024-02-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-000877 |
| 2023-12-1216:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000898432-23-000856 |
| 2023-11-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-017757 |
| 2023-11-0316:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017594 |
| 2023-11-0308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017501 |
| 2023-08-0316:07 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013212 |
| 2023-08-0308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013067 |
| 2023-06-1516:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-23-011142 |
| 2023-05-1008:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000898432-23-000278 |
| 2023-05-0408:33 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-007988 |
| 2023-05-0408:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-007985 |
| 2023-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001558370-23-007283 |
| 2023-03-0217:14 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001104659-23-028003 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.